MXI1 is located at 10q24-25 [7], [8] a region where loss of heterozygosity (LOH) has been reported to occur in several human cancers, including prostate tumors, renal cell carcinomas, meningiomas, endometrial cancers, small-cell lung cancers and gliomas [9]. This evidence concerns the gene MXI1 and central nervous system cancer.